ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DSM Will Divest Side-Chain Business

by Patricia L. Short
November 24, 2008 | APPEARED IN VOLUME 86, ISSUE 47

DSM has agreed to sell DSM Deretil, a maker of antibiotic side chains, to a management group. DSM says the transaction will allow its anti-infectives unit "to fully focus on its core future activity" in generic antibiotics. Deretil President Lluis Franquesa says his company will proceed with a previously announced plan to close part of its main plant in Villaricos, Spain, and move production to China. Deretil's sales are about $44 million per year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment